Results 91 to 100 of about 106,748 (296)
Integrating single‐cell and spatial transcriptomics reveals human ventricular septal defect (VSD) as a disease of microenvironmental insufficiency and structural remodeling arrest. Attenuated endothelial‐fibroblast crosstalk, alongside downregulated THBS1/TGF‐β1 and MMP2 signaling networks, impairs the endothelial‐to‐mesenchymal transition (EndoMT) and
Xiaoyuan Zhang +9 more
wiley +1 more source
Hua-Fei Li,1–3,* Cong Wu,4,* Ting Chen,5,* Ge Zhang,1 He Zhao,1 Chang-Hong Ke,1 Zheng Xu21International Joint Cancer Institute, Translation Medicine Institute, 2Planning Division, Scientific Research Department, 3Tumor Immunology and Gene Therapy ...
Zhang G +6 more
core
(A) Flow cytometric examination of surface expression of the CD20-CAR and CD19. Mock, non-transduced T cells. The CAR was detected with a PE-conjugated mouse anti-human IgG (Fc-specific) antibody. CD19 expression was detected with an APC conjugated mouse
Jinjuan Wang (498583) +11 more
core +1 more source
CD20 Antibody Primes B Lymphocytes for Type I Interferon Production [PDF]
CD20 is a B cell surface marker that is expressed in various stages in B lymphocytes and certain lymphomas. Clinical administration of CD20 antibody, such as rituximab, is used widely to treat human B-cell lymphomas and other diseases.
Zhang, Luwen +8 more
core +2 more sources
CD86‐positive mature tertiary lymphoid structures were associated with increased intratumoral CD8+ T‐cell infiltration, a higher proportion of Granzyme B‐expressing CD8+ T cells in an exploratory analysis, and favorable clinical outcomes in pancreatic ductal adenocarcinoma.
Takaomi Seki +10 more
wiley +1 more source
IntroductionThe B-cell-specific marker CD20 is expressed in various B-cell malignancies, including B-cell acute lymphoblastic leukemia (B-ALL) and serves as a key target for immunotherapies.
Moein Kermani +10 more
doaj +1 more source
Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy
The aim of adoptive T-cell therapy of cancer is to selectively confer immunity against tumor cells. Autoimmune side effects, however, remain a risk, emphasizing the relevance of a suicide mechanism allowing in vivo elimination of infused T cells.
Marieke Griffioen +5 more
doaj +1 more source
Scintigraphic acquisition of athymic Nude mice bearing CD20+ (R) and CD20- (L) xenografts.
Mice were grafted with tumor CD20+ on right flank (R, dark gray arrow) and CD20- on left flank (L, light gray head arrow). Mice were injected intravenously with 35–37 MBq of 99mTc anti-CD20 IgG-SH (A), 99mTc anti-EGFR IgG-SH (B) or 99mTc-anti-IsoLink® (C)
Isabelle Quelven (803908) +3 more
core +1 more source
ABSTRACT Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the Francophone Group of Hematological Cytogenetics (Groupe Francophone de Cytogénétique Hématologique, GFCH) conducted a ...
Florence Nguyen‐Khac +16 more
wiley +1 more source
Expression and folding of CD20 in the E. coli inner membrane.
Cell surface expression and orientation of CD20 was assessed from spheroplasts of E. coli cells expressing either Uni-CD20 (blue), LE-CD20 (green) or an empty control vector (red) treated with Alexa-488 conjugated anti-CD20 antibody to the extracellular ...
Jenny Bostrom (168293) +8 more
core +1 more source

